LABP Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 1.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Landos Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Landos Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Landos Biopharma Share Price & Price History

Current Price: $22.93
Price Change: Price Increase of +0.13 (0.57%)
As of 05/23/2024 09:56 PM ET

This chart shows the closing price history over time for LABP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Landos Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/23/2022Rtw Investments, LpMajor ShareholderSell30,000$6.90$207,000.00397,572View SEC Filing Icon  
12/20/2021Josep Bassaganya-RieraMajor ShareholderSell3,319$47.50$157,652.50View SEC Filing Icon  
12/17/2021Josep Bassaganya-RieraMajor ShareholderSell3,600$48.40$174,240.00View SEC Filing Icon  
12/15/2021Josep Bassaganya-RieraMajor ShareholderSell4,300$50.20$215,860.00View SEC Filing Icon  
12/13/2021Josep Bassaganya-RieraMajor ShareholderSell4,000$53.70$214,800.00View SEC Filing Icon  
12/10/2021Josep Bassaganya-RieraMajor ShareholderSell4,000$57.70$230,800.00View SEC Filing Icon  
12/8/2021Josep Bassaganya-RieraMajor ShareholderSell2,553$66.50$169,774.50View SEC Filing Icon  
12/6/2021Josep Bassaganya-RieraMajor ShareholderSell3,600$61.70$222,120.00View SEC Filing Icon  
12/3/2021Josep Bassaganya-RieraMajor ShareholderSell3,600$61.50$221,400.00View SEC Filing Icon  
12/1/2021Josep Bassaganya-RieraMajor ShareholderSell3,223$70.10$225,932.30View SEC Filing Icon  
11/29/2021Josep Bassaganya-RieraMajor ShareholderSell1,543$75.80$116,959.40View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Landos Biopharma (NASDAQ:LABP)

49.06% of Landos Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LABP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Landos Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/20/2024Virtu Financial LLC14,537$0.31M0.0%N/A0.464%Search for SEC Filing on Google Icon
5/16/2024Black Maple Capital Management LP10,405$0.22M0.1%N/A0.332%Search for SEC Filing on Google Icon
4/17/2024Deltec Asset Management LLC50,000$1.07M0.2%N/A1.603%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC1,486,991$6.26M0.2%-90.0%47.660%Search for SEC Filing on Google Icon
11/14/2022RTW Investments LP3,975,722$2.58M0.1%-7.0%9.876%Search for SEC Filing on Google Icon
11/1/2022OUP Management Co. LLC1,237,667$0.80M1.3%-23.3%3.074%Search for SEC Filing on Google Icon
10/31/2022Green Square Capital Advisors LLC84,500$55K0.0%N/A0.210%Search for SEC Filing on Google Icon
7/19/2022OUP Management Co. LLC1,612,764$1.17M1.6%-11.7%4.006%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC105,208$0.51M0.0%N/A0.262%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC8,274$39K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/3/2022OUP Management Co. LLC1,827,478$8.77M4.0%N/A4.555%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC112,933$1.65M0.0%-11.4%0.282%Search for SEC Filing on Google Icon
11/12/2021Botty Investors LLC128,750$1.88M0.6%+4.9%0.321%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.233,616$3.41M0.0%-20.6%0.582%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG2,693$39K0.0%-30.0%0.007%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.18,831$0.28M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund2,756$40K0.0%-62.5%0.007%Search for SEC Filing on Google Icon
11/2/2021Allworth Financial LP5,286$77K0.0%N/A0.013%Search for SEC Filing on Google Icon
10/22/2021Strs Ohio11,400$0.17M0.0%+660.0%0.028%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP899,106$10.39M0.9%+22.5%2.241%Search for SEC Filing on Google Icon
8/16/2021Tudor Investment Corp Et Al17,793$0.21M0.0%-71.3%0.044%Search for SEC Filing on Google Icon
8/16/2021State Street Corp92,367$1.07M0.0%+88.1%0.230%Search for SEC Filing on Google Icon
8/13/2021Botty Investors LLC122,781$1.42M0.5%+26.0%0.306%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC127,518$1.47M0.0%+15.3%0.318%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.305,185$3.52M0.0%+61.9%0.761%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp14,029$0.16M0.0%+37.8%0.035%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.294,043$3.40M0.0%+14.7%0.733%Search for SEC Filing on Google Icon
5/27/2021Davidson Kempner Capital Management LP50,000$0.48M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/19/2021Logos Global Management LP734,000$7.07M0.7%N/A1.830%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC15,361$0.15M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/18/2021Zimmer Partners LP90,100$0.87M0.0%N/A0.225%Search for SEC Filing on Google Icon
5/18/2021Tudor Investment Corp Et Al61,899$0.60M0.0%N/A0.154%Search for SEC Filing on Google Icon
5/18/2021Orbimed Advisors LLC681,000$6.56M0.1%N/A1.697%Search for SEC Filing on Google Icon
5/18/2021Davidson Kempner Capital Management LP50,000$0.48M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/18/2021Old Well Partners LLC18,316$0.18M0.1%N/A0.046%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System9,518$92K0.0%N/A0.024%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C450,000$4.33M0.1%N/A1.122%Search for SEC Filing on Google Icon
5/17/2021Perceptive Advisors LLC17,960,839$159.69M2.0%N/A44.770%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP213,335$2.05M0.0%N/A0.532%Search for SEC Filing on Google Icon
5/17/2021Caas Capital Management LP40,000$0.39M0.0%N/A0.100%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC10,219$98K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.70,000$0.67M0.1%N/A0.174%Search for SEC Filing on Google Icon
5/14/2021Laurion Capital Management LP10,000$96K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/14/2021RTW Investments LP4,275,722$38.33M0.6%N/A10.658%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC91,309$0.88M0.1%N/A0.228%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp10,182$98K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/13/2021Botty Investors LLC97,477$0.94M0.3%N/A0.243%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp74,359$0.72M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC110,559$1.06M0.0%N/A0.276%Search for SEC Filing on Google Icon
5/12/2021Ensign Peak Advisors Inc125,000$1.20M0.0%N/A0.312%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.375,021$3.61M0.0%N/A0.935%Search for SEC Filing on Google Icon
5/11/2021Teacher Retirement System of Texas10,000$96K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund7,300$70K0.0%N/A0.018%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.256,290$2.47M0.0%N/A0.639%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.3,677$35K0.0%N/A0.009%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Landos Biopharma logo
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that is in Phase 2 clinical trial to treat ulcerative colitis (UC) and completed Phase 1 to treat Crohn's disease (CD). The company's preclinical candidates in development include LABP-73, an oral and small molecule NLRX1 pathway agonist for the treatment of asthma and eosinophilic disorders; LABP-66 is an oral and small molecule NLRX1 pathway agonist for the treatment of multiple sclerosis and neurodegenerative disorders; and LABP-69, an oral PLXDC2 agonist for the treatment of rheumatoid arthritis, UC, and CD. The company has a license and collaboration agreement with LianBio Respiratory Limited to develop, manufacture, and commercialize omilancor and NX-13. Landos Biopharma, Inc. was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Read More on Landos Biopharma

Today's Range

Now: $22.93
Low: $22.75
High: $22.94

50 Day Range

MA: $22.54
Low: $21.51
High: $22.93

52 Week Range

Now: $22.93
Low: $2.50
High: $22.94

Volume

50,800 shs

Average Volume

19,700 shs

Market Capitalization

$71.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.14